Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SGMT
SGMT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SGMT News
SAGIMET BIOSCIENCES INC: CANACCORD GENUITY INCREASES TARGET PRICE FROM $28 TO $49
6d ago
moomoo
Sagimet Biosciences Announces New Drug Trial Plans
Apr 27 2026
Fool
Sagimet Plans Phase 3 Trial Launch for Denifanstat in 2026
Apr 27 2026
stocktwits
NASDAQ 100 Pre-Market Activity Overview
Apr 27 2026
NASDAQ.COM
Sagimet Biosciences Stock Surges 30% on $175M Offering Announcement
Apr 27 2026
seekingalpha
Sagimet Biosciences Prices $175 Million Underwritten Offering
Apr 27 2026
Newsfilter
Sagimet Biosciences Appoints New Chief Medical Officer
Apr 20 2026
NASDAQ.COM
Sagimet Biosciences Reports Q4 2025 Financial Results
Mar 11 2026
seekingalpha
Sagimet Stock Increases Following Acne Treatment Success
Feb 03 2026
Barron's
Guggenheim Initiates Buy on Sagimet Biosciences with Blockbuster Potential
Feb 03 2026
seekingalpha
Sagimet Biosciences Shares Drop 9% Following Partner's Trial Data Release
Jan 29 2026
seekingalpha
Ascletis' Denifanstat Receives Approval for Acne Treatment
Jan 29 2026
PRnewswire
Ascletis' Denifanstat Receives Approval for Acne Treatment
Jan 29 2026
Newsfilter
CancerVAX Appoints Dr. George Kemble as Senior Scientific Advisor
Jan 27 2026
Yahoo Finance
China SXT Pharmaceuticals Launches AI Initiative, Stock Rises 13.6%
Jan 09 2026
NASDAQ.COM
Sagimet Biosciences Advances F4 MASH Combination Therapy Development
Dec 18 2025
Newsfilter
Show More News
